Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Revenues	$ 15,078,316	$ 11,600,904
Direct product costs	6,473,477	4,835,632
Gross Profit	8,604,839	6,765,272
Operating Expenses:
Research and development	10,282,635	8,114,377
Sales and marketing	5,677,141	4,634,012
General and administrative	5,569,654	5,138,410
Total Operating Expenses	21,529,430	17,886,799
Operating Loss	(12,924,591)	(11,121,527)
Interest expense	(2,904,454)	(874,713)
Change in fair value of derivative liabilities	(142,200)	0
Other income (expense)	4,951	(30,526)
Total Other Expenses, net	(3,041,703)	(905,239)
Net Loss	$ (15,966,294)	$ (12,026,766)
Net loss per share - basic and diluted (in dollars per share)	$ (2.25)	$ (2.17)
Weighted average common shares outstanding - basic and diluted (in shares)	7,105,880	5,550,373
Product [Member]
Revenues	$ 14,683,492	$ 10,558,570
Royalty and Non-recurring Engineering [Member]
Revenues	$ 394,824	$ 1,042,334